An Update on Current and Emergent Therapies for Essential ThrombocytosisByDaniel H. Foley, MD,Kristen Pettit, MDSeptember 6th 2023The therapeutic landscape for myeloproliferative neoplasms is shifting toward a goal of meaningful disease modification.